929557-07-3

Upstream product

• 100-51-6 benzyl alcohol 
• 1123-00-8 2-cyclopentylacetic acid 
• 164472-98-4 benzyl-2-cyclopentyl acetate 

Downstream Products

• 929556-35-4 benzyl 2-keto-2-cyclopentylacetate 
• 1420039-29-7 3-(cis-4-((tert-butyldimethylsilyl)oxy)cyclohexyl)-4-cyclopentylfuran-2,5-dione 
• 1420039-31-1 3-cyclopentyl-4-(cis-4-hydroxycyclohexyl)furan-2,5-dione 

Relevant academic research and scientific papers

NDM INHIBITOR

An objective of the present invention is to provide a novel NDM (New Delhi metallo-β-lactamase) inhibitor that functions as a drug for restoring the antibacterial activity of β-lactam antibiotics that have been inactivated as a result of decomposition by NDM. According to the present invention, there is provided an NDM inhibitor contains a compound represented by general formula (I):

Metallo-beta-lactamase inhibitors

A new metallo-β-lactamase inhibitor which acts as a medicament for inhibiting the inactivation of β-lactam antibiotics and recovering anti-bacterial activities is disclosed. The maleic acid derivatives having the general formula (I) have metallo-β-lactamase inhibiting activities. It is possible to recover the anti-bacterial activities of β-lactam antibiotics against metallo-β-lactamase producing bacteria by combining the compound of the general formula (I) with β-lactam antibiotics.

Anticoagulant peptide aldehyde derivatives

PCT No. PCT/HU97/00027 Sec. 371 Date Apr. 2, 1999 Sec. 102(e) Date Apr. 2, 1999 PCT Filed Jun. 5, 1997 PCT Pub. No. WO97/46523 PCT Pub. Date Dec. 11, 1997This invention relates to peptide aldehyde derivatives of formula (I): D-Xaa-Pro-Arg-H, wherein Xaa r